Skip to main content
. 2021 Jul 21;40(1):75–85. doi: 10.1007/s11604-021-01174-w

Table 4.

Comparison of treatment response assessments in harmonized EORTC criteria and harmonized imPERCIST

Harmonized imPERCIST
CMR PMR SMD PMD Total
Harmonized EORTC critera
 CMR 3 0 0 0 3
 PMR 1 4 0 0 5
 SMD 0 1 3 0 4
 PMD 0 0 2 13 15
 Total 4 5 5 13 27

EORTC European Organization for Research and Treatment of Cancer, imPERCIST immunotherapy-modified positron emission tomography response criteria in solid tumors, CMR complete metabolic response, PMR partial metabolic response, SMD stable metabolic disease, PMD progressive metabolic disease